References

  1. Hartgens, F., Cheriex, E. C., & Kuipers, H. (2003). Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes. International journal of sports medicine, 24(05), 344-351.
  2. Evans, N. A. (1997). Gym and tonic: a profile of 100 male steroid users. British journal of sports medicine, 31(1), 54-58.
  3. Wood, R. I. (2004). Reinforcing aspects of androgens. Physiology & behavior, 83(2), 279-289.
  4. Friedl, K. E., Hannan Jr, C. J., Jones, R. E., & Plymate, S. R. (1990). High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. Metabolism, 39(1), 69-74.
  5. Schänzer, W. (1996). Metabolism of anabolic androgenic steroids. Clinical chemistry, 42(7), 1001-1020.